MYSTERIOUS: Beckley psytech - You Need To See This

Drug campaigner Amanda Feilding has been at the forefront of psychedelic science for half a century. Now her sons are joining the firm. Will the Beckley research empire change the way we treat mental ill health asks Alexandra Jones

London researchers to assess possible therapeutic benefits of new synthetic drug made from mebufotenin

Private psychedelics medicine company Beckley Psytech Ltd. has acquired 100% of clinical-stage life sciences company Eleusis Therapeutics Ltd., entitling the former to full developmental and commercial rights of the latter’s assets. 

This article by Freddie Earlam was originally published on Microdose and appears here with permission. If the industry-defining research already conducted at UK centers such as Imperial College, King’s college or even Exeter University’s recent Ketamine Research isn’t enough to convince you, then two more crucial factors surely will. Firstly, a new ‘accelerated pathway’ has…